Vilazodone for the Treatment of Posttraumatic Stress Disorder

Phase 4 Completed 59 enrolled Southern California Institute for Research and Education Forest Laboratories · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether vilazodone is effective in the treatmen of Posttraumatic Stress Disorder (PTSD)and co-morbid mild or more depression.

Timeline

Start: 2012-10
Primary completion: 2015-12
Completion: 2015-12

Outcome

Missed primary endpoint

paper No significant differences were observed between the groups on any of the primary or secondary outcome measures. PMID 28858440 ↗

Publications

Ramaswamy S, Driscoll D, Reist C, Smith LM, Albers LJ, Rose J, Nguyen L, Monga V, Doria R, Hollifield M. A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vilazodone	Small molecule	40 mg	—